127. 前頭側頭葉変性症 Frontotemporal lobar degeneration Clinical trials / Disease details


臨床試験数 : 89 薬物数 : 105 - (DrugBank : 33) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 117

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04408625
(ClinicalTrials.gov)
November 9, 202021/5/2020Phase 1/2 Clinical Trial of PR006 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of PR006A in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)Frontotemporal DementiaBiological: PR006;Drug: Methylprednisolone;Drug: Sirolimus;Drug: Prednisone;Drug: RituximabPrevail TherapeuticsEli Lilly and CompanyRecruiting30 Years80 YearsAll15Phase 1/Phase 2United States;Australia;Spain